SCHEMBL7414962

SCHEMBL7414962

N=C(N)NOCCCOc1ccc(C[C@H](NS(=O)(=O)c2ccc(Cl)c([N+](=O)[O-])c2)C(=O)OC(=O)C(F)(F)F)cc1

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 13/20 0.44
MCL1 Q07820 8/20 0.44
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7420503 0.91 BCL2 (0.38) BCL2MCL1
SCHEMBL7415413 0.91 TMPRSS6 (0.38) MCL1
Trifluoroacetic Acid SCHEMBL7414956 0.90 BCL2 (0.49) BCL2MCL1
SCHEMBL7414953 0.88 ITGB3 (0.43)
SCHEMBL7695355 0.88 BCL2 (0.49) BCL2MCL1
SCHEMBL7412096 0.87 MEN1 (0.43)
SCHEMBL7423552 0.87 MAPT (0.41) BCL2MCL1
SCHEMBL7416087 0.87 POLB (0.37)
SCHEMBL7414434 0.87 F2 (0.42)
SCHEMBL7416602 0.86 ITGB3 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344484-B1 TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-02-05 US disclosed
EP-1159262-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000047552-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed